✦ LIBER ✦

Phase I study of the humanised anti-EGFR monoclonal antibody matuzumab (EMD 72000) combined with gemcitabine in advanced pancreatic cancer

✍ Scribed by Graeven, U; Kremer, B; Südhoff, Th; Killing, B; Rojo, F; Weber, D; Tillner, J; ünal, C; Schmiegel, W

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of a phase I trial of the humani

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 139 KB

53 A phase I study of epidermal growth f

✍ C. Bokemeyer; C. Kollmannsberger; M. Schittenhelm; F. Honecker; H.J. Ahrens; J. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 334 KB

Phase II study of nimotuzumab, a humaniz

✍ Dirk Strumberg, Beate Schultheis, M. E. Scheulen, R. A. Hilger, J. Krauss, N. Ma 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 144 KB

732 POSTER Phase I clinical study of the

✍ J. Soriano; N. Batista; M. Lima; R. Rodríguez; M.V. López; A. Montenegro; M. Ram 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 83 KB

A phase I pharmacokinetic (PK) and seria

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 256 KB

A phase I study evaluating the role of t

✍ J. P. Arnoletti; A. Frolov; M. Eloubeidi; K. Keene; J. Posey; T. Wood; Edward Gr 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 369 KB